NYSE:SQZ
Delisted
Sqz Biotechnologies Company Stock News
$0.0630
+0 (+0%)
At Close: Nov 28, 2023
Why SQZ Biotechnologies Sank on Friday
07:16pm, Friday, 12'th Feb 2021
The cell-squeezing specialist priced a new stock issue.
SQZ Biotechnologies Under Pressure After $60M Equity Raise At 9% Discount
11:18am, Friday, 12'th Feb 2021
SQZ Biotechnologies Co (NYSE: SQZ) prices its underwritten public offering of 3 million common shares at $20 per share. Underwriters have an option to purchase up to an additional 450,000 shares.
WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies (NYSE: SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced that the company's Investigationa
WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies (NYSE: SQZ), a cell therapy company developing novel potential treatments for multiple therapeutic areas, announced today that the Immune Toleran
SQZ Biotech to Present at Evercore ISI Virtual HealthCONx Conference
06:45am, Monday, 23'rd Nov 2020
WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies (NYSE:SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced that Armon Sharei, PhD, chief exec
U.S. IPO Week Ahead: The IPO Market Takes A Break During The Shortened Holiday Week
12:35pm, Sunday, 22'nd Nov 2020
The IPO market is taking a break during the shortened Thanksgiving week, with just one IPO and two SPACs scheduled to raise $900 million. Russian e-commerce company Ozon Holdings plans to raise $750 m
